Serological diagnosis of leprosy in patients in Vietnam by enzyme-linked immunosorbent assay with Mycobacterium leprae-derived major membrane protein II

Clinical and Vaccine Immunology

Volumn 15, Issue 12, 2008, Pages 1755-1759

  Kai, Masanori ^a   Phuc, Nhu Ha Nguyen ^b   Thi, Thuy Huong Hoang ^b   An, Hoang Nguyen ^b   Fukutomi, Yasuo ^a   Maeda, Yumi ^a   Miyamoto, Yuji ^a   Mukai, Tetsu ^a   Fujiwara, Tsuyoshi ^c   Tan, Thanh Nguyen ^b   Makino, Masahiko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Quyhoa National Leprosy and Dermato Venereology Hospital   (Viet Nam)

^c NARA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MEMBRANE PROTEIN II; PHENOLIC GLYCOLIPID I; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MEDICAL STAFF; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; PAUCIBACILLARY LEPROSY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SERODIAGNOSIS; SEROLOGY; SERUM; VIET NAM;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOLIPIDS; HUMANS; LEPROSY; MEMBRANE PROTEINS; MYCOBACTERIUM LEPRAE; SENSITIVITY AND SPECIFICITY;

EID: 57349142381     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00148-08     Document Type: Article

References (34)

1. Agis, F., P. Schlich, J. L. Cartel, C. Guidi, and M. A. Bach. 1988. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy. Int. J. Lepr. Other Mycobact. Dis. 56:527-535.
2. Beck, J. R., and E. K. Schultz. 1986. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch. Pathol. Lab. Med. 110:13-20.
3. Bührer-Sékula, S., H. L. Smits, G. C. Gussenhoven, J. van Leeuwen, S. Amador, T. Fujiwara, P. R. Klatser, and L. Oskam. 2003. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J. Clin. Microbiol. 41:1991-1995.
4. Cartel, J. L., S. Chanteau, J. P. Boutin, R. Plichart, P. Richez, J. F. Roux, and J. H. Grosset. 1990. Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands. Int. J. Lepr. Other Mycobact. Dis. 58:512-517.
5. Chanteau, S., J. L. Cartel, P. Celerier, R. Plichart, S. Desforges, and J. Roux. 1989. PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy. Int. J. Lepr. Other Mycobact. Dis. 57:735-743.
6. Chanteau, S., P. Glaziou, C. Plichart, P. Luquiaud, R. Plichart, J. F. Faucher, and J. L. Cartel. 1993. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia. Int. J. Lepr. Other Mycobact. Dis. 61:533-541.
7. Chaturvedi, V., S. Sinha, B. K. Girdhar, and U. Sengupta. 1991. On the value of sequential serology with a Mycobacterium leprae-specific antibody competition ELISA in monitoring leprosy chemotherapy. Int. J. Lepr. Other Mycobact. Dis. 59:32-40.
8. Cho, S. N., R. V. Cellona, T. T. Fajardo, Jr., R. M. Abalos, E. C. dela Cruz, G. P. Walsh, J. D. Kim, and P. J. Brennan. 1991. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens. Int. J. Lepr. Other Mycobact. Dis. 59:25-31.
9. Cho, S. N., R. V. Cellona, L. G. Villahermosa, T. T. Fajardo, Jr., M. V. Balagon, R. M. Abalos, E. V. Tan, G. P. Walsh, J. D. Kim, and P. J. Brennan. 2001. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy. Clin. Diagn. Lab. Immunol. 8:138-142.
10. Donoghue, H. D., J. Holton, and M. Spigelman. 2001. PCR primers that can detect low levels of Mycobacterium leprae DNA. J. Med. Microbiol. 50:177-182.
11. Reference deleted.
12. Fujiwara, T., S. W. Hunter, S. N. Cho, G. O. Aspinall, and P. J. Brennan. 1984. Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy. Infect. Immun. 43:245-252.
13. Gelber, R. H., F. Li, S. N. Cho, S. Byrd, K. Rajagopalan, and P. J. Brennan. 1989. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy. Int. J. Lepr. Other Mycobact. Dis. 57:744-751.
14. Hunter, S. W., and P. J. Brennan. 1981. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J. Bacteriol. 147:728-735.
15. Izumi, S., T. Fujiwara, M. Ikeda, Y. Nishimura, K. Sugiyama, and K. Kawatsu. 1990. Novel gelatin particle agglutination test for serodiagnosis of leprosy in the field. J. Clin. Microbiol. 28:525-529.
16. Job, C. K. 1989. Nerve damage in leprosy. Int. J. Lepr. Other Mycobact. Dis. 57:532-539.
17. Kai, M., Y. Maeda, S. Maeda, Y. Fukutomi, K. Kobayashi, Y. Kashiwabara, M. Makino, M. A. Abbasi, M. Z. Khan, and P. A. Shah. 2004. Active surveillance of leprosy contacts in country with low prevalence rate. Int. J. Lepr. Other Mycobact. Dis. 72:50-53.
18. Maeda, Y., T. Mukai, M. Kai, Y. Fukutomi, H. Nomaguchi, C. Abe, K. Kobayashi, S. Kitada, R. Maekura, I. Yano, N. Ishii, T. Mori, and M. Makino. 2007. Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy. FEMS Microbiol. Lett. 272:202-205.
19. Maeda, Y., T. Mukai, J. Spencer, and M. Makino. 2005. Identification of an immunomodulating agent from Mycobacterium leprae. Infect. Immun. 73: 2744-2750.
20. Martinez, A. N., C. F. P. C. Britto, J. A. C. Nery, E. P. Sampaio, M. R. Jardim, E. N. Sarno, and M. O. Moraes. 2006. Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy. J. Clin. Microbiol. 44:3154-3159.
21. Meeker, H. C., W. R. Levis, E. Sersen, G. Schuller-Levis, P. J. Brennan, and T. M. Buchanan. 1986. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories. Int. J. Lepr. Other Mycobact. Dis. 54:530-539.
22. Meeker, H. C., G. Schuller-Levis, F. Fusco, M. A. Giardina-Becket, E. Sersen, and W. R. Levis. 1990. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan. Int. J. Lepr. Other Mycobact. Dis. 58:503-511.
23. Reference deleted.
24. Pessolani, M. C., D. R. Smith, B. Rivoire, J. McCormick, S. A. Hefta, S. T. Cole, and P. J. Brennan. 1994. Purification, characterization, gene sequence, and significance of a bacterioferritin from Mycobacterium leprae. J. Exp. Med. 180:319-327.
25. Phetsuksiri, B., J. Rudeeaneksin, P. Supapkul, S. Wachapong, K. Mahotarn, and P. J. Brennan. 2006. A simplified reverse transcriptase PCR for rapid detection of Mycobacterium leprae in skin specimens. FEMS Immunol. Med. Microbiol. 48:319-328.
26. Schuring, R. P., F. J. Moet, D. Pahan, J. H. Richardus, and L. Oskam. 2006. Association between anti-PGL-I IgM and clinical and demographic parameters in leprosy. Lepr. Rev. 77:343-355.
27. Sekar, B., R. N. Sharma, G. Leelabai, D. Anandan, B. Vasanthi, G. Yusuff, M. Subramanian, and M. Jayasheela. 1993. Serological response of leprosy patients to Mycobacterium leprae specific and mycobacteria specific antigens: possibility of using these assays in combinations. Lepr. Rev. 64:15-24.
28. Siegel, S., and N. J. Castellan, Jr. 1988. Non-parametric statistics for the behavioral sciences, 2nd edition. McGraw-Hill, New York, NY.
29. Soebono, H., and P. R. Klatser. 1991. A seroepidemiological study of leprosy in high- and low-endemic Indonesian villages. Int. J. Lepr. Other Mycobact. Dis. 59:416-425.
30. Stoner, G. L. 1979. Importance of the neural predilection of Mycobacterium leprae in leprosy. Lancet ii(8150):994-996.
31. van Beers, S., M. Hatta, and P. R. Klatser. 1999. Seroprevalence rates of antibodies to phenolic glycolipid-I among school children as an indicator of leprosy endemicity. Int. J. Lepr. Other Mycobact. Dis. 67:243-249.
32. van Beers, S., S. Izumi, B. Madjid, Y. Maeda, R. Day, and P. R. Klatser. 1994. An epidemiological study of leprosy infection by serology and polymerase chain reaction. Int. J. Lepr. Other Mycobact. Dis. 62:1-9.
33. Verhagen, C., W. Faber, P. Klatser, A. Buffing, B. Naafs, and P. Das. 1999. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions. Am. J. Pathol. 154:1793-1804.
34. World Health Organization. 2007. Global leprosy situation. Wkly. Epidemiol. Rec. 82:225-232.